June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
A phenotypic analysis of uveitic diseases using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO)
Author Affiliations & Notes
  • Alexandra Vitale
    John A. Moran Eye Center, University of Utah Health, Salt Lake City, Utah, United States
  • Lydia Sauer
    John A. Moran Eye Center, University of Utah Health, Salt Lake City, Utah, United States
  • Natalie Kaye Modersitzki
    John A. Moran Eye Center, University of Utah Health, Salt Lake City, Utah, United States
  • Marissa Bucci Larochelle
    John A. Moran Eye Center, University of Utah Health, Salt Lake City, Utah, United States
  • Akbar Shakoor
    John A. Moran Eye Center, University of Utah Health, Salt Lake City, Utah, United States
  • Albert T Vitale
    John A. Moran Eye Center, University of Utah Health, Salt Lake City, Utah, United States
  • Paul S Bernstein
    John A. Moran Eye Center, University of Utah Health, Salt Lake City, Utah, United States
  • Footnotes
    Commercial Relationships   Alexandra Vitale, Tesseract Health Inc (C); Lydia Sauer, Tesseract Health Inc (C); Natalie Modersitzki, None; Marissa Larochelle, None; Akbar Shakoor, None; Albert Vitale, None; Paul Bernstein, Tesseract Health Inc (C)
  • Footnotes
    Support  Unrestricted Departmental Grant From Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2315. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexandra Vitale, Lydia Sauer, Natalie Kaye Modersitzki, Marissa Bucci Larochelle, Akbar Shakoor, Albert T Vitale, Paul S Bernstein; A phenotypic analysis of uveitic diseases using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Invest. Ophthalmol. Vis. Sci. 2021;62(8):2315.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Uveitis is a group of ocular inflammatory diseases that can derive from both infectious and noninfectious causes. This study investigates patients diagnosed with a variety of uveitic diseases utilizing Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO).

Methods : 49 eyes of 49 subjects with varying uveitic diseases (mean age 48 ± 19 years) and 49 age-matched healthy subjects (p=0.899) were investigated in this study. Clinical grading of uveitic disease subtypes were confirmed by uveitis specialists (ATV, AS, MBL). FLIO images of a 30° retinal field centered at the fovea were acquired using a prototype Heidelberg Engineering Spectralis-based FLIO. FLIO lifetimes were recorded in short (498-560 nm, SSC) and long (560-720 nm, LSC) spectral wavelength channels, with mean autofluorescence lifetimes (tm) calculated and analyzed.

Results : FLIO is able to categorize uveitic diseases based on phenotype, and lifetimes of patients with uveitic diseases showed significant prolongation in central, inner and outer ring regions of the ETDRS grid compared to age-matched controls (p=0.03, p=0.006, p=0.003, respectively). FLIO lifetimes were variable depending on the type of disease with shortened lifetimes correlating to regions of active inflammation or in areas adjacent to lesions.

Conclusions : FLIO can effectively discriminate between various uveitic diseases with high specificity. While prolonged FLIO lifetimes were found in regions of atrophy or scarring, shortened FLIO lifetimes were observed in regions adjacent to lesions and in patients with clinically active ocular inflammation. FLIO may provide insight into understanding these complex diseases, as well as monitoring disease activity, progression, and remission.

This is a 2021 ARVO Annual Meeting abstract.

 

FLIO lifetimes and fundus autofluorescence (FAF) intensity images from various uveitic diseases compared to a healthy control. FLIO lifetimes are shown in the short (498-560 nm, SSC) and long (560-720 nm, LSC) spectral channels.

FLIO lifetimes and fundus autofluorescence (FAF) intensity images from various uveitic diseases compared to a healthy control. FLIO lifetimes are shown in the short (498-560 nm, SSC) and long (560-720 nm, LSC) spectral channels.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×